论文部分内容阅读
目的:采用EQ-5D-5L量表对乳腺癌患者进行健康效用值的测量,为今后开展乳腺癌临床治疗的成本-效用分析提供方法借鉴和基础数据支持。方法:采用EQ-5D-5L量表对621名乳腺癌患者进行面对面问卷调查。结果:用EQ-5D-5L量表测量的乳腺癌患者的平均健康效用值为0.83±0.16(95%可信区间为0.82~0.85,中位数为0.87);被调查患者的教育程度、家庭收入以及治疗方案会对健康效用值产生一定影响。结论:采用EQ-5D-5L量表对乳腺癌患者进行健康效用值的测量具有重要研究价值,应加快研制适用中国人群的EQ-5D-5L量表的效用值积分体系。
Objective: To use the EQ-5D-5L scale to measure the health utility value of breast cancer patients, and to provide methodological support and basic data support for future cost-effectiveness analysis of breast cancer clinical treatment. METHODS: A face-to-face questionnaire was conducted on 621 breast cancer patients using the EQ-5D-5L scale. Results: The average health utility value of breast cancer patients measured with the EQ-5D-5L scale was 0.83±0.16 (95% confidence interval 0.82 to 0.85, median 0.87); education level, family of the investigated patients Income and treatment options will have an impact on health utility values. Conclusion: The EQ-5D-5L scale has important research value for the measurement of the value of health utility in breast cancer patients. It should speed up the development of the utility value integral system of EQ-5D-5L scale for Chinese population.